DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Aktueller Standort:
>
> This Story


Log in oder Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Rad Oncology Homepage

Japanese startup to develop ultra-compact proton therapy system Designed to replace conventional radiotherapy systems

FDA okays Philips' MR-only radiotherapy simulator, MRCAT pelvis Create treatment plans for bladder, rectal, anal and cervical cancer

Varian to acquire Cancer Treatment Services International for $283 million Enables production of multidisciplinary solutions

Varian acquires CyberHeart, enters cardiac radioablation market Emerging technology could benefit treatment of irregular heartbeats

New 12-year study highlights value of PRRT, based on long-term outcomes Understanding peptide receptor radionuclide therapy

Korean cancer center aims to deploy heavy ion therapy in 2022 Plans also call for the onboarding of more CR and MR systems

RefleXion Medical secures $60 million for approval and launch of BgRT system Can detect and treat multiple tumors in the same session

Radiation oncologists appeal to Congress to safeguard radiotherapy treatment Protecting cancer patients' access to value-based care

Using ERISA to end proton therapy denials Insights from Timothy J. Rozelle and Lisa S. Kantor, from Kantor & Kantor, LLP on getting insurers to provide coverage

Philips unveils IntelliSpace Radiation Oncology system at ESTRO Manages complexity and efficiency of radiology departments

The first Flash irradiation demonstration
with IBA technology took place at
University Medical Centre Groningen in
The Netherlands

IBA tech plays first-time role in flash therapy demonstration

by John R. Fischer , Staff Reporter
The first Flash irradiation demonstration performed with IBA technology took place this month at the University Medical Centre Groningen (UMCG) in The Netherlands.

Researchers at the Dutch-based institute performed the practice in an IBA gantry treatment room, marking a step forward for IBA and its medical and research partners in integrating Flash irradiation as a clinical treatment.

Story Continues Below Advertisement

RaySafe helps you avoid unnecessary radiation

RaySafe solutions are designed to minimize the need for user interaction, bringing unprecedented simplicity & usability to the X-ray room. We're committed to establishing a radiation safety culture wherever technicians & medical staff encounter radiation.



“Being the first proton therapy center that has treated patients in The Netherlands, we have the vision that the clinical introduction of new and emerging radiation technologies should be more evidence-based,” said Hans Langendijk, chair of radiation oncology at UMCG, in a statement. “As the pioneer of the model-based approach for selecting patients for proton therapy in The Netherlands, we look forward to better understand the radiobiological effect of Flash irradiation and predict the benefits and outcomes of Flash therapy for patients.”

A noninvasive radiotherapy technique, Flash irradiation delivers high doses at ultra-high speeds in less than one second, saving time on, and prolonged exposure to, radiation during procedures. The phenomenon requires a dose superior to 8 Gy and a dose rate above 33 Gy/sec, compared to conventional dose rates for radiotherapy which are 1-7 cGy/sec. It is theorized that the high dose rate depletes the oxygen within tissues, rendering healthy ones radioresistant and allowing dose to reach levels that destroy tumor tissues, even in high hypoxia, with almost no impact on healthy surrounding tissue.

The demonstration, which took place on March 1, consisted of several Flash irradiations delivered at the isocenter of one of the facility’s two gantry treatment rooms. Using IBA Proteus solution, researchers obtained positive results that exceed the conditions required for the Flash effect with a dose rate up to 200 Gy/sec.

It follows a number of events revolving around the practice, including funding for two accelerator-based projects in X-ray and proton therapy at the Department of Energy’s SLAC National Accelerator Laboratory and Stanford University, respectively; and the launch of Varian’s ProBeam 360° platform, which is expected to open access to flash therapy and other potential next-generation treatments.

“We are excited about the recent results obtained in Groningen, demonstrating IBA’s technology leadership in Flash therapy research, a novel technique that has the potential to change the way patients are treated,” said Olivier Legrain, chief executive officer at IBA, in a statement. "Building on a unique and open culture of collaborative innovation, IBA continues its commitment to further develop Flash therapy by partnering with the largest and most experienced user community in studying the radiobiology of proton Flash irradiation and help our clinical partners move faster to bring value to the clinic.”

Back to HCB News
  Pages: 1

Rad Oncology Homepage


You Must Be Logged In To Post A Comment

Werben
Erhöhen Sie Ihren Bekanntheitsgrad
Auktionen + Privatverkäufe
Den besten Preis erzielen
Geräte/Geräteteile kaufen
Den günstigsten Preis finden
Daily News
Die neuesten Nachrichten lesen
Übersicht
Alle DOTmed Benutzer durchsuchen
Ethik auf DOTmed
Unseren Ethik-Standard anzeigen
Gold-Parts Verkäufer-Programm
PH-Anfragen erhalten
Gold Service Dealer-Programm
Anfragen empfangen
Gesundheitsdienstleister
Alle Gesundheitsdienstleister-Tools anzeigen
Jobs/Training
Einen Job suchen
Parts Hunter +EasyPay
Angebote für Geräteteile erhalten
Kürzlich zertifiziert
Kürzlich zertifizierte Benutzer anzeigen
Kürzlich bewertet
Kürzlich zertifizierte Benutzer anzeigen
Rental Central
Geräte billiger mieten
Geräte/Geräteteile verkaufen
Das meiste Geld erhalten
Service-Techniker Forum
Hilfe und Beratung finden
Einfache Angebots-Anfrage
Angebote für Geräte erhalten
Virtuelle Messe
Service für Geräte finden
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED